CATALOGO DEI PRODOTTI DELLA RICERCA

VINANTE, Fabrizio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.385
EU - Europa 5.495
AS - Asia 1.677
SA - Sud America 15
OC - Oceania 10
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 7
Totale 13.598
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.355
GB - Regno Unito 2.443
CN - Cina 1.468
IT - Italia 528
SE - Svezia 524
FR - Francia 509
IE - Irlanda 447
DE - Germania 402
FI - Finlandia 368
UA - Ucraina 151
JP - Giappone 57
RU - Federazione Russa 49
TR - Turchia 37
VN - Vietnam 37
BE - Belgio 31
IR - Iran 29
CA - Canada 26
IN - India 22
NL - Olanda 9
AU - Australia 7
CZ - Repubblica Ceca 7
SC - Seychelles 6
BR - Brasile 5
CL - Cile 5
EU - Europa 5
HK - Hong Kong 5
CH - Svizzera 4
SA - Arabia Saudita 4
AL - Albania 3
LV - Lettonia 3
NZ - Nuova Zelanda 3
PL - Polonia 3
SG - Singapore 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BG - Bulgaria 2
CM - Camerun 2
CO - Colombia 2
HU - Ungheria 2
IL - Israele 2
KG - Kirghizistan 2
KR - Corea 2
MD - Moldavia 2
NO - Norvegia 2
PA - Panama 2
PH - Filippine 2
RO - Romania 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AT - Austria 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BO - Bolivia 1
CR - Costa Rica 1
ES - Italia 1
GE - Georgia 1
IQ - Iraq 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MS - Montserrat 1
PE - Perù 1
PK - Pakistan 1
PT - Portogallo 1
ZA - Sudafrica 1
Totale 13.598
Salva come PNG Salva come JPEG
Città #
Southend 2.242
Jacksonville 1.362
Chandler 938
Woodbridge 715
Ashburn 578
Houston 545
Dublin 444
Ann Arbor 390
Wilmington 200
Lawrence 173
Princeton 173
Beijing 168
Shenyang 162
Jinan 160
Nanjing 159
Verona 124
Sindelfingen 98
New York 87
Hebei 86
Zhengzhou 71
Tianjin 68
Changsha 65
Boardman 57
Taizhou 56
Nanchang 55
Haikou 54
Helsinki 52
Ningbo 52
Jiaxing 45
Hangzhou 41
Guangzhou 36
Milan 36
Taiyuan 33
Lancaster 32
Brussels 31
Falls Church 29
Fairfield 24
Norwalk 24
Seattle 24
Fuzhou 22
Redmond 22
San Francisco 22
Dong Ket 21
Lanzhou 19
Lonigo 19
Columbus 17
Dearborn 17
Düsseldorf 17
Washington 15
Auburn Hills 14
Bologna 13
Redwood City 13
Rome 13
Kochi 12
Philadelphia 12
Leawood 11
Kemerovo 10
Toronto 10
Los Angeles 9
Zanjan 9
Clearwater 8
Shinchiba 8
Ardabil 7
Paris 7
Châtenay-Malabry 6
London 6
Mahé 6
Ypsilanti 6
Cambridge 5
Edinburgh 5
Melbourne 5
Montréal 5
Sacramento 5
San Diego 5
Tappahannock 5
Buffalo 4
Chicago 4
Cossato 4
Genoa 4
Groningen 4
Montreal 4
Orsogna 4
Qingdao 4
San Mateo 4
Trento 4
York 4
Andover 3
Ankara 3
Bolzano 3
Des Moines 3
Detroit 3
Falkenstein 3
Genova 3
Kunming 3
Las Vegas 3
Palermo 3
Pozza 3
Riva 3
Riyadh 3
Saint Louis 3
Totale 10.181
Salva come PNG Salva come JPEG
Nome #
Preferential release of high amounts of interleukin-8 by myeloid blasts showing monocytic differentiation 350
Immunocitologia e immunoistologia delle cellule midollari normali e neoplastiche 311
HB-EGF/HER -1 SIGNALLING IN BONE MARROW MESENCHYMAL STEM CELLS: INDUCING CELL EXPANSION AND PREVENTING REVERSIBLY MULTI-LINEAGE DIFFERENTIATION 133
Serum levels of soluble interleukin-2 receptor in hairy cell leukaemia: a reliable marker of neoplastic bulk 126
Increased levels of soluble interleukin-2 receptor in the serum of patients with human immunodeficiency virus infection 122
Cellular senescence markers p16INK4 and p21CIP1/WAF are predictors of Hodgkin's lymphoma outcome 121
Alpha (p55) and beta (p75) chains of the interleukin-2 receptor are expressed by AML blasts 120
Endothelin B Receptor (Etbr) expression by human malignant plasma cells: preliminary evidence for a role of the endothelin axis in multiple myeloma. 120
I marcatori delle cellule linfoidi 119
Protein Tyrosine Phosphatase Receptor Type γ Is a Functional Tumor Suppressor Gene Specifically Downregulated in Chronic Myeloid Leukemia 117
High serum levels of soluble interleukin 2 receptor in patients with B chronic lymphocytic leukemia 116
L'alfa interferone nei pazienti con Hairy Cell Leukemia attiva il sistema NK, ma non induce un'attività citotossica specifica verso le cellule hairy 115
Alpha-interferon activated cytotoxic lymphocytes in hairy cell leukemia patients: evaluation of cytotoxic events 115
α-bisabolol is an effective proapoptotic agent against BCR-ABL+ cells in synergism with Imatinib and Nilotinib 115
Down-regulation of protein tyrosine phosphatase gamma (PTPRG) in chronic myeloid leukemia (CML) 113
Biological prognostic factors in indolent lymphoma 112
a (p55) and b (p75) chains of interleukin-2 receptor are expressed by AML blasts 112
Alpha-interferon activates the natural killer system in patients with hairy cell leukemia 110
Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways 108
Soluble forms of p55-IL-2R alpha, CD8, and CD30 molecules as markers of lymphoid cell activation in infectious mononucleosis 107
Leucemie 106
Soluble interleukin-2 receptors in the sera of patients with hairy cell leukemia: relationship with the effect of recombinant alpha-interferon therapy on clinical parameters and natural killer in vitro activity 105
Endothelin-1 receptor blockade as new possible therapeutic approach in multiple myeloma. 105
IL-8 mRNA expression and IL-8 production by acute myeloid leukemia cells 104
A study of the crosstalk between CD30 and CXCR4 103
HUMAN T-LYMPHOBLASTIC LEUKAEMIA CELLS PRODUCE IL-8 IN RESPONSE TOCXCL12 SECRETED BY NORMAL BONE MARROW STROMA 103
Espressione e ruolo funzionale di CD30/CD30L e Fas/FasL in cellule endoteliali umane 102
Monoterapia empirica con ceftazidime nelle infezioni di pazienti neutropenici affetti da emopatie maligne 102
Highly concentrated urine-purified Tac peptide fails to inhibit IL-2-dependent cell proliferation in vitro 102
Serum levels of p55 and p75 soluble TNF receptors in adult acute leukaemia at diagnosis: correlation with clinical and biological features and outcome 102
Immunophenotypic approach to the detection of minimal residual disease in acute leukemia 100
BONE MARROW-DERIVED STROMAL CELLS INHIBIT SPONTANEOUS APOPTOSIS IN NORMAL AND NEOPLASTIC THYMOCYTES 100
CXCL12 and [N33A]CXCL12 in 5637 and HeLa Cells: Regulating HER1 Phosphorylation via Calmodulin/Calcineurin 98
Ceftazidime and amikacin as empiric antibiotic therapy of febrile granulocytopenic patients with hematological malignancies. Report of 171 consecutive episodes 97
Soluble interleukin-2 receptor in the serum of patients with Hodgkin's Disease: A new biological marker of disease activity 97
Alpha-interferon activates the natural killer system in patients with hairy cell leukemia 96
Expression and role of CD30/CD30L and Fas/FasL in human endothelial cells 95
Hairy cell leukemia in kidney transplantation: lesson from a rare disorder. 95
Immunohistochemical and flow cytometric analysis of the expression of cyclin-dependent kinase 6 (CDK6, PLSTIRE) in cortical thymocytes and T-cell lymphoblastic lymphoma/leukemia 94
The Sesquiterpene Oil {alpha}-Bisabolol Induces Apoptosis of B-Chronic Lymphocytic Leukemia Primary Cells 94
Pro-apoptotic activity of α-bisabolol in preclinical models of primary human acute leukemia cells 94
Increased serum levels of soluble interleukin-2 receptor in patients with systemic lupus erythematosus and rheumatoid arthritis 93
Gram-negative septicemia in patients with hematologic malignancies 93
CXCL12-MEDIATED NF-KAPPAB AND C-JUN ACTIVATION REGULATES INTERLEUKIN 8 PRODUCTION IN HUMAN T-LYMPHOBLASTIC LEUKEMIA 93
Immunohistochemical demonstration of follicular dendritic cells in bone marrow involvement of B-cell chronic lymphocytic leukemia. 92
Trisomy 8 in myelodysplasia and acute leukemia is constitutional in 15-20% of cases 91
Bone marrow-, but not thymus-, derived stromal cells inhibit spontaneous apoptosis and induce proliferation in blasts of T-lineage ALL 91
Increased levels of soluble CD8 molecule in the serum of patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related disorders 90
Natural killer cell function and lymphoid subpopulations in acute non-lymphoblastic leukaemia in complete remission 89
Assetto citochinico e pattern del CD30 durante la maturazione del sistema immunitario 88
Cellular antigens and soluble molecules and cytokine receptors in leukemia and lymphoma: biological role and clinical applications 88
Circulating levels of soluble CD23 reflect clinical and biological features of leukemic B-cell chronic lymphoproliferative disorders 88
Immunologic abnormalities in angioimmunoblastic lymphadenopathy 87
CD30 e assetto citochinico dei linfociti T, valutato mediante analisi citofluorimetrica, in un caso di sindrome da iper-IgE asintomatica 87
Origin of the soluble interleukin 2 receptor in the serum of patients with hairy cell leukemia 87
Soluble interleukin-2 receptors in the serum of patients with Hodgkin's disease 87
AML blasts express heparin-binding epidermal growth factor-like growth factor (HB-EGF)/diphtheria toxin receptor 87
Natural killer cell function and lymphoid subpopulations in acute non-lymphoblastic leukaemia in complete remission 86
Differential expression of cyclin-dependent kinase 6 (CDK6, PLSTIRE) in cortical thymocytes and T-cell lymphoblastic lymphoma/leukemia. 86
Studio immunologico delle popolazioni linfoidi normali nella leucemia acuta mieloide in remissione completa. Evidenze di un possibile controllo immunologico della ricaduta 85
Il recettore per l'interleuchina-2 sulle cellule normali e neoplastiche 85
Immunologic evidence of a strong association between non-Hodgkin lymphoma and simian virus 40 85
Sesquiterpene α-bisabolol, which binds to Bid in lipid rafts, induces apoptosis in BCR/ABL+ cell lines through membrane depolarization. 83
ICAM-1 tissue overexpression associated with increased serum levels of its soluble form in Hodgkin's disease 82
Comparative analysis of normal versus CLL B-lymphocytes reveals patient-specific variability in signaling mechanisms controlling LFA-1 activation by chemokines 82
Increased serum levels of soluble IL-2 receptor, CD30 and CD8 molecules, and gamma-interferon in angioimmunoblastic lymphadenopathy: possible pathogenetic role of immunoactivation mechanisms 81
Granulocyte-macrophage colony-stimulating factor induces expression of heparin-binding epidermal growth factor-like growth factor/diphtheria toxin receptor and sensitivity to diphtheria toxin in human neutrophils 81
Bone marrow-derived stromal cells inhibit spontaneous apoptosis and induce proliferation in blasts of T acute lymphoblastic leukaemia: the role of interleukin 7 81
CD30 triggering by agonistic antibodies regulates CXCR4 expression and CXCL12 chemotactic activity in the cell line L540. 81
HB-EGF/HER-1 signaling in bone marrow mesenchymal stem cells: inducing cell expansion and reversibly preventing multilineage differentiation 81
The CD4 molecule belongs to the phenotypic repertoire of most cases of acute myeloid leukemia 80
L'immunofenotipo nelle leucemie 80
Morphological and Functional Changes in the Peritumoral Adipose Tissue of Colorectal Cancer Patients 79
Correlation between clinical features and circulating levels of soluble intercellular adhesion molecule-1 in Hodgkin's disease 78
High serum levels of soluble interleukin-2 receptors in sarcoidosis 78
Thymic epithelial cell-derived interleukin-7 promotes survival of human T-cell acute lymphoblastic leukemia 78
Progressive polarization towards a Th(c)1 cytokine pattern during age-dependent maturation of the immune response inversely correlates with CD30 cell expression and serum concentration 77
Empiric therapy of infections in hematologic malignancies: a prospective randomized trial 77
Soluble interleukin-2 receptor in hairy cell leukemia: A reliable marker of disease 77
Presence of interleukin-2 receptor gamma chain transcript in AML blasts [letter] 76
CD30+ L540 cells express CCR5 and CXCR4 molecules, CCR3 mRNA and release RANTES and MIP-1alfa 76
Rearrangement for the T-cell receptor gene and co-expression of immature T-cell markers and natural killer cell phenotype, in a patient with acute lymphoblastic leukaemia 76
CD30 antigen and cellular biology of Reed-Sternberg cells [letter; comment] 75
CD30 antigen and cellular biology of Reed-Sternberg cells 75
Le molecole solubili in oncoematologia 75
Soluble molecules in lymphoproliferative diseases 75
Serum levels of soluble CD30 in chronic hepatitis type B 75
High serum level of the soluble form of CD30 molecule in the early phase of HIV-1 infection as an independent predictor of progression to AIDS 74
Functional analysis of cytotoxic cells in patients with acute nonlymphoblastic leukemia in complete remission 74
Correlation between soluble interleukin-2 receptor and neoplastic bulk in hairy cell leukemia 74
Interleukin 7 requirement for survival of T-cell acute lymphoblastic leukemia and human thymocytes on bone marrow stroma. 74
Serum levels of soluble interleukin-2 receptor in Hodgkin's disease: relationship with clinical stage, tumor burden and treatment outcome. A longitudinal study 73
JAK2 tyrosine kinase mediates integrin activation induced by CXCL12 in B-cell chronic lymphocytic leukemia 73
In reply to Schäfer et al: new evidence on the role of endothelin-1 axis as a potential therapeutic target in multiple myeloma 73
The Plant-Derived Agent {alpha}-Bisabolol Induces Apoptosis of Leukemic Blasts Ex Vivo. 72
Growth and differentiation signalling in myeloma cells. 71
Serum levels of soluble CD30 molecule (Ki-1 antigen) in Hodgkin's disease. Relationship with disease activity and clinical stage 71
Role of CD30 molecule in HIV-1 infection 70
Role for IFN-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. 70
Mitochondrial-Mediated Apoptosis by the Sesquiterpene Oil {alpha}-Bisabolol and Its Synergism with Imatinib and Nilotinib In BCR-ABL+ Cells. 70
Totale 9.612
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.438
article - articoli 23.858
book - libri 0
conference - conferenze 10.152
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.428
Totale 70.876
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019177 0 0 0 0 0 0 0 0 0 33 24 120
2019/20201.792 222 35 17 165 115 286 154 184 89 193 86 246
2020/20211.716 132 262 80 174 177 219 15 162 144 16 250 85
2021/20221.641 125 522 13 92 109 48 37 77 51 80 170 317
2022/20232.836 229 247 254 539 243 716 14 165 311 27 58 33
2023/20241.291 66 113 162 152 173 209 105 292 10 9 0 0
Totale 13.750